Viewing Study NCT02733094


Ignite Creation Date: 2025-12-25 @ 2:00 AM
Ignite Modification Date: 2026-03-03 @ 3:54 PM
Study NCT ID: NCT02733094
Status: COMPLETED
Last Update Posted: 2023-04-12
First Post: 2016-03-28
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Single-arm Study to Assess a Potential Effect of Anti-IL-17 (Secukinumab) in the Treatment of Pyoderma Gangrenosum
Sponsor: Technical University of Munich
Organization:

Organization Data

Organization:
Class: OTHER
Study ID: CAIN547ADE01T
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators

Collaborators

Name Class View
None INDUSTRY View